{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:21:00Z","timestamp":1783549260417,"version":"3.55.0"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Non-alcoholic fatty liver disease develops from simple steatosis to non-alcoholic steatohepatitis (NASH), which then potentially develops into liver cirrhosis. It is a serious threat to human health. Therefore, investigating the formation and development mechanism of non-alcoholic fatty liver disease (NAFLD) is of great significance. Herein, an early model of NAFLD was successfully established by feeding rats with a high-fat and choline-deficient diet. Liver tissue samples were obtained from rats in the fatty liver model group (NAFL) and normal diet control group (CON). Afterward, transcriptome and lipidomic analysis was performed. Transcriptome results revealed that 178 differentially expressed genes were detected in NAFL and CON groups. Out of which, 105 genes were up-regulated, 73 genes were downregulated, and 8 pathways were significantly enriched. A total of 982 metabolites were detected in lipidomic analysis. Out of which 474 metabolites were significantly different, 273 were up-regulated, 201 were downregulated, and 7 pathways were significantly enriched. Based on the joint analysis, 3 common enrichment pathways were found, including cholesterol metabolism and fat digestion and absorption metabolic pathways. Overall, in the early stage of NAFLD, a small number of genetic changes caused a strong response to lipid components. The strongest reflection was glycerides and glycerophospholipids. A significant increase in fatty acid uptake accompanied by cholesterol metabolism is the most prominent metabolic feature of the liver in the early stage of NAFLD. In the early stage of fatty liver, the liver had shown the characteristics of NASH.<\/jats:p>","DOI":"10.3389\/fnut.2021.733197","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T04:22:17Z","timestamp":1631852537000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Combined Transcriptomic and Lipidomic Analysis Reveals Dysregulated Genes Expression and Lipid Metabolism Profiles in the Early Stage of Fatty Liver Disease in Rats"],"prefix":"10.3389","volume":"8","author":[{"given":"Ruina","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/hep.29302","article-title":"Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis","volume":"66","author":"Xiao","year":"2017","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cphy.c170012","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves-Bezerra","year":"2017","journal-title":"Compr Physiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3390\/jcm10040792","article-title":"Roles of ceramides in non-alcoholic fatty liver disease","volume":"10","author":"Hajduch","year":"2021","journal-title":"J Clin Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.3389\/fimmu.2019.02893","article-title":"macrophage function in the pathogenesis of non-alcoholic fatty liver disease: the mac attack","volume":"10","author":"Oates","year":"2019","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"852","DOI":"10.7150\/ijbs.19370","article-title":"Emerging roles of SIRT1 in fatty liver diseases","volume":"13","author":"Ding","year":"2017","journal-title":"Int J Biol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.metabol.2019.153947","article-title":"AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease","volume":"99","author":"Nikolaou","year":"2019","journal-title":"Metabolism"},{"key":"B10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/children4060046","article-title":"The role of lipid and lipoprotein metabolism in non-alcoholic fatty liver disease","volume":"4","author":"Perla","year":"2017","journal-title":"Children"},{"key":"B11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3390\/ijms18020434","article-title":"Proteome characteristics of non-alcoholic steatohepatitis liver tissue and associated hepatocellular carcinomas","volume":"18","author":"Kakehashi","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"B13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.4254\/wjh.v12.i8.436","article-title":"Lipidomics in non-alcoholic fatty liver disease","volume":"12","author":"Kartsoli","year":"2020","journal-title":"World J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3390\/metabo10070283","article-title":"Transcriptional regulation in non-alcoholic fatty liver disease","volume":"10","author":"Steensels","year":"2020","journal-title":"Metabolites"},{"key":"B15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/hep.27173","article-title":"Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease","volume":"60","author":"Bedossa","year":"2014","journal-title":"Hepatology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1093\/mp\/sst080","article-title":"A novel integrated method for large-scale detection, identification, and quantification of widely targeted metabolites: application in the study of rice metabolomics","volume":"6","author":"Chen","year":"2013","journal-title":"Mol Plant"},{"key":"B17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12986-021-00553-4","article-title":"Integrative proteomic and lipidomic analysis of Kaili Sour Soup-mediated attenuation of high-fat diet-induced nonalcoholic fatty liver disease in a rat model","volume":"18","author":"Cong","year":"2021","journal-title":"Nutr Metab"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.3389\/fmicb.2019.01423","article-title":"A Purified anthraquinone-glycoside preparation from rhubarb ameliorates type 2 diabetes mellitus by modulating the gut microbiota and reducing inflammation","volume":"10","author":"Cui","year":"2019","journal-title":"Front Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"667622","DOI":"10.3389\/fnut.2021.667622","article-title":"Lipidomic and transcriptomic analysis of the longissimus muscle of luchuan and duroc pigs","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Nutr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3390\/cells8111358","article-title":"Why bile acids are so important in Non-Alcoholic Fatty Liver Disease (NAFLD) progression","volume":"8","author":"Gottlieb","year":"2019","journal-title":"Cells"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e96969","DOI":"10.1371\/journal.pone.0096969","article-title":"Gallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD mice","volume":"9","author":"Chao","year":"2014","journal-title":"PLoS ONE"},{"key":"B22","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1139\/cjpp-2020-0259","article-title":"Theobromine ameliorates nonalcoholic fatty liver disease by regulating hepatic lipid metabolism via mTOR signaling pathway in vivo and in vitro","volume":"99","author":"Wei","year":"2020","journal-title":"Can J Physiol Pharmacol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/biom10091275","article-title":"Hepatic lipidomics and molecular imaging in a murine non-alcoholic fatty liver disease model: insights into molecular mechanisms","volume":"10","author":"Rodr\u00edguez-Calvo","year":"2020","journal-title":"Biomolecules"},{"key":"B24","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2337\/dbi18-0032","article-title":"Epigenetic regulation of hepatic lipogenesis: role in hepatosteatosis and diabetes","volume":"69","author":"Viscarra","year":"2020","journal-title":"Diabetes"},{"key":"B26","doi-asserted-by":"publisher","first-page":"596329","DOI":"10.3389\/fcell.2020.596329","article-title":"MicroRNA-20a-5p ameliorates non-alcoholic fatty liver disease via inhibiting the expression of CD36","volume":"8","author":"Wang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"23793","DOI":"10.1074\/jbc.M116.749283","article-title":"Very low density lipoprotein assembly is required for cAMP-responsive element-binding protein h processing and hepatic apolipoprotein A-IV expression","volume":"291","author":"Cheng","year":"2016","journal-title":"J Biol Chem"},{"key":"B28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/met.2019.0038","article-title":"The effect of low glycemic index and glycemic load diets on hepatic fat mass, insulin resistance, and blood lipid panels in individuals with nonalcoholic fatty liver disease","volume":"17","author":"Parker","year":"2019","journal-title":"Metab Syndr Relat Disord"},{"key":"B29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12944-016-0321-5","article-title":"Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease","volume":"15","author":"Paglialunga","year":"2016","journal-title":"Lipids Health Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.bbrc.2020.01.143","article-title":"MicroRNA-103 represses hepatic de novo lipogenesis and alleviates NAFLD via targeting FASN and SCD1","volume":"524","author":"Zhang","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B31","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-16-0513","article-title":"Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones","volume":"234","author":"Geisler","year":"2017","journal-title":"J Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"16810","DOI":"10.1038\/s41598-019-53346-4","article-title":"Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism","volume":"9","author":"Montandon","year":"2019","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1194\/jlr.M001966","article-title":"A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats","volume":"51","author":"Buqu\u00e9","year":"2010","journal-title":"J Lipid Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1136\/gut.2010.222844","article-title":"Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C","volume":"60","author":"Miquilena-Colina","year":"2011","journal-title":"Gut"},{"key":"B36","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"B37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev.biochem.67.1.199","article-title":"The caveolae membrane system","volume":"67","author":"Anderson","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"B38","doi-asserted-by":"publisher","first-page":"7773","DOI":"10.1096\/fj.202000194R","article-title":"Characterization of the variability in the extent of nonalcoholic fatty liver induced by a high-fat diet in the genetically diverse Collaborative Cross mouse model","volume":"34","author":"de Conti","year":"2020","journal-title":"FASEB J"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","article-title":"The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease","volume":"1859","author":"van der Veen","year":"2017","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1700696","DOI":"10.1002\/mnfr.201700696","article-title":"Green tea polyphenol EGCG Alleviates metabolic abnormality and fatty liver by decreasing bile acid and lipid absorption in mice","volume":"62","author":"Huang","year":"2018","journal-title":"Mol Nutr Food Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00216-020-02996-9","article-title":"Analysis of serum lysophosphatidylethanolamine levels in patients with non-alcoholic fatty liver disease by liquid chromatography-tandem mass spectrometry","volume":"413","author":"Yamamoto","year":"2021","journal-title":"Anal Bioanal Chem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"11053","DOI":"10.1074\/jbc.274.16.11053","article-title":"An alternative splicing form of phosphatidylserine-specific phospholipase A1 that exhibits lysophosphatidylserine-specific lysophospholipase activity in humans","volume":"274","author":"Nagai","year":"1999","journal-title":"J Biol Chem"},{"key":"B43","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.bbrc.2018.05.078","article-title":"Non-alcoholic fatty liver disease: insights from sphingolipidomics","volume":"504","author":"Montefusco","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B44","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3389\/fendo.2020.00505","article-title":"Too much of a good thing? an evolutionary theory to explain the role of ceramides in NAFLD","volume":"11","author":"Poss","year":"2020","journal-title":"Front Endocrinol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"16568","DOI":"10.1074\/jbc.273.26.16568","article-title":"Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis","volume":"273","author":"Zhou","year":"1998","journal-title":"J Biol Chem"},{"key":"B46","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/MOL.0000000000000688","article-title":"Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism","volume":"31","author":"Liu","year":"2020","journal-title":"Curr Opin Lipidol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1194\/jlr.RA119000171","article-title":"ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters","volume":"60","author":"Morton","year":"2019","journal-title":"J Lipid Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00726-014-1894-9","article-title":"Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease","volume":"47","author":"Lake","year":"2015","journal-title":"Amino Acids"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/oby.21855","article-title":"Metabolomic profiling distinction of human nonalcoholic fatty liver disease progression from a common rat model","volume":"25","author":"Han","year":"2017","journal-title":"Obesity"},{"key":"B50","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3390\/nu9050492","article-title":"NAFLD and atherosclerosis are prevented by a natural dietary supplement containing curcumin, silymarin, guggul, chlorogenic acid and inulin in mice fed a high-fat diet","volume":"9","author":"Amato","year":"2017","journal-title":"Nutrients"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e8793","DOI":"10.15252\/msb.20188793","article-title":"Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease","volume":"15","author":"Niu","year":"2019","journal-title":"Mol Syst Biol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"109734","DOI":"10.1016\/j.biopha.2019.109734","article-title":"Huang-Qi San improves glucose and lipid metabolism and exerts protective effects against hepatic steatosis in high fat diet-fed rats","volume":"126","author":"Li","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"B53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.mce.2019.04.005","article-title":"Disruption of ESR1 alters the expression of genes regulating hepatic lipid and carbohydrate metabolism in male rats","volume":"490","author":"Khristi","year":"2019","journal-title":"Mol Cell Endocrinol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e91997","DOI":"10.1371\/journal.pone.0091997","article-title":"Reduced UCP-1 content in in vitro differentiated beige\/brite adipocytes derived from preadipocytes of human subcutaneous white adipose tissues in obesity","volume":"9","author":"Carey","year":"2014","journal-title":"PLoS ONE"},{"key":"B55","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.micron.2015.03.009","article-title":"Increases in endothelial caveolin-1 and cavins correlate with cirrhosis progression","volume":"76","author":"Yokomori","year":"2015","journal-title":"Micron"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e00905","DOI":"10.7554\/eLife.00905.015","article-title":"Cavin-3 dictates the balance between ERK and Akt signaling","volume":"2","author":"Hernandez","year":"2013","journal-title":"Elife"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1007\/s00125-015-3683-8","article-title":"The Ia-2\u03b2 intronic miRNA, miR-153, is a negative regulator of insulin and dopamine secretion through its effect on the Cacna1c gene in mice","volume":"58","author":"Xu","year":"2015","journal-title":"Diabetologia"},{"key":"B58","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.1113\/jphysiol.2012.239574","article-title":"T-type amino acid transporter TAT1 (Slc16a10) is essential for extracellular aromatic amino acid homeostasis control","volume":"590","author":"Mariotta","year":"2012","journal-title":"J Physiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e2914","DOI":"10.1002\/dmrr.2914","article-title":"Blood pathway analyses reveal differences between prediabetic subjects with or without dyslipidaemia. The cardiovascular risk in young Finns study","volume":"33","author":"Laaksonen","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"key":"B60","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S1388-1981(00)00053-6","article-title":"ABC transporters in lipid transport","volume":"1486","author":"Borst","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"B61","doi-asserted-by":"publisher","first-page":"158811","DOI":"10.1016\/j.bbalip.2020.158811","article-title":"12\u03b1-Hydroxylated bile acid induces hepatic steatosis with dysbiosis in rats","volume":"1865","author":"Lee","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"B62","doi-asserted-by":"publisher","first-page":"S287","DOI":"10.1194\/jlr.R800077-JLR200","article-title":"Expanding functions of lipoprotein receptors","volume":"50","author":"Herz","year":"2009","journal-title":"J Lipid Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1074\/jbc.M111.310888","article-title":"Up-regulation of ATP binding cassette transporter A1 expression by very low density lipoprotein receptor and apolipoprotein E receptor 2","volume":"287","author":"Chen","year":"2012","journal-title":"J Biol Chem"},{"key":"B64","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cyto.2014.07.250","article-title":"Effect of Astragalus polysaccharides on expression of TNF-\u03b1, IL-1\u03b2 and NFATc4 in a rat model of experimental colitis","volume":"70","author":"Yang","year":"2014","journal-title":"Cytokine"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.jhep.2020.07.030","article-title":"Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice","volume":"73","author":"Du","year":"2020","journal-title":"J Hepatol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3389\/fcell.2020.00593","article-title":"SLIT2 overexpression in periodontitis intensifies inflammation and alveolar bone loss, possibly via the activation of MAPK pathway","volume":"8","author":"Wang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.jhep.2015.07.033","article-title":"Activation of Slit2-Robo1 signaling promotes liver fibrosis","volume":"63","author":"Chang","year":"2015","journal-title":"J Hepatol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1042\/BCJ20190709","article-title":"CXCL13 is a differentiation- and hypoxia-induced adipocytokine that exacerbates the inflammatory phenotype of adipocytes through PHLPP1 induction","volume":"476","author":"Kusuyama","year":"2019","journal-title":"Biochem J"},{"key":"B69","doi-asserted-by":"publisher","first-page":"107222","DOI":"10.1016\/j.intimp.2020.107222","article-title":"Apolipoprotein A4 regulates the immune response in carbon tetrachloride-induced chronic liver injury in mice","volume":"90","author":"Wang","year":"2021","journal-title":"Int Immunopharmacol"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2021.733197\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T04:22:21Z","timestamp":1631852541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2021.733197\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":69,"alternative-id":["10.3389\/fnut.2021.733197"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2021.733197","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,17]]},"article-number":"733197"}}